What's in a name ? La construction sociale du risque du sida chez les consommateurs de drogue à Harlem

What's in a Name ?La construction sociale du risque du sidachez les consommateurs de drogue à HarlemCet essai trace l'histoire de vie de cinq personnes vivant à Harlem, une communauté appauvrie caractérisée par des taux élevés d'usage de drogue et de prévalence du VIH/sida ; ces personnes s'injectent toutes de la drogue par voie intraveineuse. Chaque portrait tente de documenter la façon dont est perçu le risque de l'infection par le VIH relativement à d'autres sortes de danger, ainsi que la manière dont ce risque est géré face à d'autres types de besoin. L'article explore la signification de ces correspondances, les situe dans le tissu social global de la communauté, notamment par rapport à la pauvreté, et en étudie les conséquences pour l'intervention en matière de sida.What's in a Name ?The Social Construction of Riskfor AIDS in the Moral Imaginationof IV Drug Users in HarlemThis essay profiles the life stories of five individuals from Harlem in New York City, an impoverished community with high levels of drug use and HIV seroprevalence. AU are intravenous drug users, and each profile is concerned with documenting the way in which risk for HIV infection is perceived relative to other kinds of dangers, as well as the way it is managed relative to other kinds of needs. The paper explores the significance of thèse correspondences, locales thèse ideas within the larger social fabric of the community, particularly as they relate to poverty, and explores the implications of thèse correspondences for AIDS intervention

Gender-Specific HIV Prevention Interventions for Women Who Use Alcohol and Other Drugs: The Evolution of the Science and Future Directions

The use of alcohol and other drugs (AODs) is an important driver of gender disparities in HIV prevalence. Consequently, there is a need for women-specific HIV interventions that are conceptualized to address (1) women’s risk behavior, their roles in sexual relationships, and gender power dynamics, and (2) other issues commonly faced by women who use AODs, such as gender-based violence and victimization. This article presents the evolution of HIV prevention intervention research with women who use AODs. It looks at three generations of women-focused HIV research interventions, including first-generation projects that started in the 1990s, second-generation efforts where projects expanded in scope and included adaptions of evidence-based interventions for global relevance, and finally third-generation projects currently underway that combine biobehavioral methods and are being implemented in real-world settings. Because women who use AODs continue to report risk behaviors related to HIV, emphasis should be placed on training scientists to conduct gender-specific studies, increasing funding for new studies, and advocating to ensure that stigma-free services are available for these at-risk women

Substance Use Among Older People Living With HIV: Challenges for Health Care Providers

Older people living with HIV (OPLWH) have higher rates of substance use (tobacco, alcohol, and other drugs) than their HIV-negative peers. Addressing health care needs of OPLWH who use substances is more challenging than for those who do not: they are highly impacted by comorbid conditions, substance use can interact with other medications (including antiretroviral therapy-ART) and reduce their effectiveness, and substance use has been associated with reduced adherence to ART and increased risky behaviors (including sexual risks). People who use substances also suffer disparities along the HIV continuum of care, resulting in lower viral suppression rates and poorer health outcomes. They are especially impacted by stigma and stress, which have implications for HIV treatment and care. Recommendations for health care providers working with OPLWH who use substances include: (1) the need to screen and refer for multiple associated conditions, and (2) training/continuing education to enhance care management and maximize health outcomes

Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.

OBJECTIVE: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. DESIGN: Systematic review and meta-analysis of prospective published and unpublished observational studies. DATA SOURCES: Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction. REVIEW METHODS: We selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model. RESULTS: Twelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23,608 person years of follow-up. Opiate substitution treatment was associated with a 54% reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95% confidence interval 0.32 to 0.67; P<0.001). There was evidence of heterogeneity between studies (I(2)=60%, χ(2)=20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment. CONCLUSION: Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment

Predictors of HIV Infection Among Women Drug Users in New York and Miami

In the US, the number of women diagnosed with AIDS continues to increase. In this study, women in New York City (East Harlem) and Miami, two sites with high rates of drug use and HIV infection, were first compared on sociodemographic variables and risk behaviors. Logistic regression analyses were used to identify significant, independent predictors of HIV infection in each city. In comparing women from the two cities, several differences in sociodemographic characteristics and drug use were observed. In both cities, ever exchanging sex for drugs and/or money was predictive of HIV infection; and in East Harlem only, other lifetime risk variables independently predicted HIV infection: drug injection, having a sexually transmitted disease, and not having graduated from high school. Results suggest that intervention efforts with women who exchange sex should be intensified in both cities. Also, further comparisons of women drug users in AIDS epicenter cities are necessary to provide information on similarities and differences in sociodemographic characteristics and individual risk behaviors. More research attention should be focused on examining the social context of HIV risk in order to develop innovative intervention strategies which focus on the link between contextual factors and HIV infection